no weight loss with semaglutide There is no one-size-fits-all approach

If you qualify, we write a starting dose of 0.25 mg weekly with a planned escalation schedule (0.25, then 0.5, then 1.0, then 1.7, then 2.4 mg) based on tolerance, side effect profile, and progress

A Discussion with Dr

The number of viable pups with indicated genotypes is shown (right)

Those taking thyroid replacement therapy (levothyroxine) may experience altered absorption or metabolism when starting GLP-1 agonists because these medications slow gastric emptying

Medications can cause either exogenous or endogenous pigmentations

Head-to-head clinical trials have observed stronger average weight management results with tirzepatide in certain populations, though individual outcomes vary based on dose, health history, and treatment duration